UK markets closed

Medistim ASA (0OCD.L)

LSE - LSE Delayed price. Currency in NOK
Add to watchlist
175.02-43.00 (-19.72%)
At close: 07:07PM BST

Medistim ASA

Økernveien 94
Oslo 0579
47 23 05 96 60

Full-time employees150

Key executives

NameTitlePayExercisedYear born
Ms. Kari Eian KrogstadCEO & President4.41MN/A1964
Mr. Thomas JakobsenChief Financial Officer2.59MN/A1969
Ms. Hæge Johanne Krogh WetterhusVice President of Marketing1.84MN/A1964
Mr. Hakon GrotheChief Innovation Officer1.77MN/AN/A
Mr. Ole Arne EiksundChief Business Development Officer1.68MN/A1967
Mr. Mike FarbelowPresident of Medistim USA Inc3.63MN/AN/A
Mr. Roger Reino MorbergVice President of Sales - APAC2.42MN/A1964
Ms. Stephanie D'Avout StenhagenVice President of Sales EMEA1.69MN/AN/A
Mr. Ole Jorgen RobsrudManaging Director of Medistim Norge AS1.78MN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in NOK.


Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Europe, Asia, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which is designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation of fragile or calcified vessels; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, the company distributes and sells third party medical equipment. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway.

Corporate governance

Medistim ASA’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.